PMC:7346000 / 505-928
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 29 | 406-419 | Chemical | denotes | galactomannan | MESH:C012990 |
| 42 | 78-101 | Disease | denotes | pulmonary aspergillosis | MESH:D055732 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T14 | 16-36 | Disease | denotes | inflammatory disease | http://purl.obolibrary.org/obo/MONDO_0021166 |
| T15 | 88-101 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
| T16 | 336-340 | Disease | denotes | CAPA | http://purl.obolibrary.org/obo/MONDO_0007163 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 178-188 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activation |
| T5 | 245-246 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 192-201 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T2 | 406-419 | Chemical | denotes | galactomannan | http://purl.obolibrary.org/obo/CHEBI_27680 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 309-321 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
LitCovid-PD-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
|---|---|---|---|---|---|
| T1 | 406-419 | GlycoEpitope | denotes | galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 103-322 | Sentence | denotes | Moreover, collateral effects of host recognition pathways required for the activation of antiviral immunity may, paradoxically, contribute to a highly permissive inflammatory environment that favors fungal pathogenesis. |